Dynamic Technology Lab Private Ltd Raises Stake in Cabot Co. (NYSE:CBT)

Dynamic Technology Lab Private Ltd increased its stake in Cabot Co. (NYSE:CBT) by 153.4% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 23,870 shares of the specialty chemicals company’s stock after purchasing an additional 14,449 shares during the quarter. Cabot accounts for 0.4% of Dynamic Technology Lab Private Ltd’s investment portfolio, making the stock its 24th largest position. Dynamic Technology Lab Private Ltd’s holdings in Cabot were worth $2,179,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently added to or reduced their stakes in the company. Trexquant Investment LP boosted its stake in shares of Cabot by 99.0% during the 4th quarter. Trexquant Investment LP now owns 109,423 shares of the specialty chemicals company’s stock worth $9,991,000 after acquiring an additional 54,429 shares in the last quarter. O Shaughnessy Asset Management LLC boosted its position in Cabot by 13.0% during the fourth quarter. O Shaughnessy Asset Management LLC now owns 28,091 shares of the specialty chemicals company’s stock worth $2,565,000 after purchasing an additional 3,235 shares in the last quarter. Brandywine Global Investment Management LLC grew its holdings in Cabot by 149.7% in the fourth quarter. Brandywine Global Investment Management LLC now owns 42,651 shares of the specialty chemicals company’s stock valued at $3,894,000 after purchasing an additional 25,572 shares during the last quarter. Dorsey Wright & Associates purchased a new position in shares of Cabot in the fourth quarter valued at $3,201,000. Finally, Schroder Investment Management Group boosted its position in shares of Cabot by 67.4% in the 4th quarter. Schroder Investment Management Group now owns 77,942 shares of the specialty chemicals company’s stock worth $7,065,000 after buying an additional 31,394 shares in the last quarter. Hedge funds and other institutional investors own 93.18% of the company’s stock.

Cabot Stock Performance

NYSE:CBT opened at $78.39 on Friday. Cabot Co. has a 1-year low of $75.51 and a 1-year high of $117.46. The firm has a 50 day simple moving average of $84.85 and a 200-day simple moving average of $97.45. The firm has a market cap of $4.25 billion, a PE ratio of 10.41, a P/E/G ratio of 0.74 and a beta of 1.04. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.00 and a quick ratio of 1.29.

Cabot (NYSE:CBT) last issued its quarterly earnings results on Monday, February 3rd. The specialty chemicals company reported $1.76 earnings per share for the quarter, topping analysts’ consensus estimates of $1.74 by $0.02. Cabot had a return on equity of 26.79% and a net margin of 10.60%. On average, equities analysts expect that Cabot Co. will post 7.57 EPS for the current year.

Cabot Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Friday, February 28th were paid a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a dividend yield of 2.19%. The ex-dividend date of this dividend was Friday, February 28th. Cabot’s dividend payout ratio is currently 22.84%.

Analyst Ratings Changes

Several equities analysts have weighed in on CBT shares. Mizuho dropped their target price on shares of Cabot from $122.00 to $110.00 and set an “outperform” rating for the company in a report on Tuesday, January 7th. StockNews.com raised shares of Cabot from a “hold” rating to a “buy” rating in a research note on Tuesday. Finally, JPMorgan Chase & Co. reduced their target price on Cabot from $105.00 to $85.00 and set an “underweight” rating on the stock in a research note on Friday, February 21st. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and two have given a buy rating to the stock. According to MarketBeat, Cabot presently has a consensus rating of “Hold” and a consensus target price of $97.00.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.